TIM-3, expressed on dysfunctional T cells, NK cells, and myeloid populations, engages with Galectin-9 produced by tumor and stromal cells, leading to CD8+ T cell exhaustion or apoptosis and further impairing dendritic cell function and interferon-γ secretion (107). The gene discussed is CD8A; the disease is neoplasm.